Celularity Inc - CELU

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q1 2026 · Q4 2025
Value (USD)
Total reported value ($000)
$3.623M
QoQ value delta ($000)
+$444K (+13.97%)
Implied price effect (QoQ)
-11.36%
Shares
Total shares
2,845,992
QoQ shares delta
+632,488 (+28.57%)
Total shares held by funds (by quarter)

Market chart (CELU)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q1 2026)

Top 25 only Full list
Partial Q1 2026 data: 38 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
C V STARR & CO INC 1,016 764,069 0.53%
VANGUARD CAPITAL MANAGEMENT LLC 826 621,105 0.0%
VANGUARD GROUP INC 751 676,650 0.0%
GEODE CAPITAL MANAGEMENT, LLC 254 191,076 0.0%
BlackRock, Inc. 169 127,501 0.0%
VANGUARD FIDUCIARY TRUST CO 106 79,874 0.0%
STATE STREET CORP 76 57,830 0.0%
Valmark Advisers, Inc. 66 49,983 0.0%
NORTHERN TRUST CORP 58 44,163 0.0%
HB Wealth Management, LLC 53 40,415 0.0%
Biltmore Family Office, LLC 46 35,000 0.01%
KEYNOTE FINANCIAL SERVICES LLC 38 29,320 0.02%
ROYAL BANK OF CANADA 24 18,000 0.0%
CenterStar Asset Management, LLC 23 17,850 0.0%
IPG Investment Advisors LLC 22 17,169 0.0%
TWO SIGMA SECURITIES, LLC 19 14,866 0.0%
XTX Topco Ltd 17 12,811 0.0%
HRT FINANCIAL LP 17 12,784 0.0%
OSAIC HOLDINGS, INC. 13 10,000 0.0%
IFP Advisors, Inc 10 8,000 0.0%
UBS Group AG 6 4,529 0.0%
Tower Research Capital LLC (TRC) 4 3,264 0.0%
WELLS FARGO & COMPANY/MN 3 2,500 0.0%
Vanguard Global Advisers, LLC 3 2,315 0.0%
SBI Securities Co., Ltd. 2 1,823 0.0%